Yale University

HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.

TitleHIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.
Publication TypeJournal Article
Year of Publication2012
AuthorsHigh, Kevin P., Mark Brennan-Ing, David B. Clifford, Mardge H. Cohen, Judith Currier, Steven G. Deeks, Sherry Deren, Rita B. Effros, Kelly Gebo, Jörg J. Goronzy, Amy C. Justice, Alan Landay, Jules Levin, Paolo G. Miotti, Robert J. Munk, Heidi Nass, Charles R. Rinaldo, Michael G. Shlipak, Russell Tracy, Victor Valcour, David E. Vance, Jeremy D. Walston, and Paul Volberding
Corporate AuthorsOAR Working Group on HIV and Aging
JournalJournal of acquired immune deficiency syndromes (1999)
Volume60 Suppl 1
PaginationS1-18
Date Published2012 Jul 1
ISSN1944-7884
KeywordsAged, Aging, Anti-HIV Agents, Biological Markers, Comorbidity, Health Services Needs and Demand, Health Services Research, HIV Infections, Humans, Middle Aged, Needs Assessment, Polypharmacy
AbstractHIV risk behaviors, susceptibility to HIV acquisition, progression of disease after infection, and response to antiretroviral therapy all vary by age. In those living with HIV, current effective treatment has increased the median life expectancy to >70 years of age. Biologic, medical, individual, social, and societal issues change as one ages with HIV infection, but there has been only a small amount of research in this field. Therefore, the Office of AIDS Research of the National Institutes of Health commissioned a working group to develop an outline of the current state of knowledge and areas of critical need for research in HIV and Aging; the working groups' findings and recommendations are summarized in this report. Key overarching themes identified by the group included the following: multimorbidity, polypharmacy, and the need to emphasize maintenance of function; the complexity of assessing HIV versus treatment effects versus aging versus concurrent disease; the inter-related mechanisms of immune senescence, inflammation, and hypercoagulability; the utility of multivariable indices for predicting outcomes; a need to emphasize human studies to account for complexity; and a required focus on issues of community support, caregivers, and systems infrastructure. Critical resources are needed to enact this research agenda and include expanded review panel expertise in aging, functional measures, and multimorbidity, and facilitated use and continued funding to allow long-term follow-up of cohorts aging with HIV.
DOI10.1353/hpu.2012.0006
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links